$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

$eltp Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224025829 Filed on July 01, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$18.80M	$17.95M	$56.63M
YoY Change	108.92%	107.71%	65.79%
Cost Of Revenue	$10.33M	$9.831M	$30.27M
YoY Change	144.2%	89.05%	72.36%
Gross Profit	$8.475M	$8.118M	$26.36M
YoY Change	78.4%	135.9%	58.83%
Gross Profit Margin	45.07%	45.23%	46.55%
Selling, General & Admin	$2.021M	$2.291M	$7.305M
YoY Change	20.56%	186.58%	41.53%
% of Gross Profit	23.85%	28.22%	27.72%
Research & Development	$2.164M	$1.718M	$6.883M
YoY Change	89.19%	-29.17%	11.02%
% of Gross Profit	25.53%	21.16%	26.12%
Depreciation & Amortization	$322.1K	$328.4K	$1.321M
YoY Change	-1.88%	-4.57%	3.36%
% of Gross Profit	3.8%	4.04%	5.01%
Operating Expenses	$4.611M	$4.390M	$15.57M
YoY Change	46.44%	24.16%	20.52%
Operating Profit	$3.864M	$3.729M	$10.79M
YoY Change	141.2%	-4062.79%	193.49%
Interest Expense	-$3.028M	-$913.1K	$588.6K
YoY Change	-2636.01%	94.62%	-47.1%
% of Operating Profit	-78.37%	-24.49%	5.46%
Other Income/Expense, Net	-$3.016M	-$822.1K	-$10.33M
YoY Change	888.1%		-3432.24%
Pretax Income	$847.8K	$1.993M	$463.1K
YoY Change	-34.63%	-332.85%	-88.38%
Income Tax	$232.0K	-$1.332M	-$19.60M
% Of Pretax Income	27.36%	-66.85%	-4232.42%
Net Earnings	$615.8K	$3.326M	$20.11M
YoY Change	-46.07%	-370.56%	464.56%
Net Earnings / Revenue	3.27%	18.53%	35.51%
Basic Earnings Per Share	$0.00		$0.02
Diluted Earnings Per Share	$0.00	$0.00	$0.02
COMMON SHARES
Basic Shares Outstanding	1.068B shares	1.018B shares	1.015B shares
Diluted Shares Outstanding	1.076B shares		1.023B shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.407M	$7.106M	$7.106M
YoY Change	-7.38%	-9.27%	-9.27%
Cash & Equivalents	$8.845M	$7.106M
Short-Term Investments
Other Short-Term Assets	$435.7K	$524.2K	$524.2K
YoY Change	-56.35%	-49.25%	-49.25%
Inventory	$13.83M	$12.93M	$12.93M
Prepaid Expenses
Receivables	$20.49M	$19.45M	$19.45M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$43.16M	$40.01M	$40.01M
YoY Change	57.26%	86.02%	86.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.57M	$10.18M	$14.61M
YoY Change	4.68%	-2.41%	39.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$94.24K	$94.24K	$94.24K
YoY Change	348.33%	348.33%	348.33%
Other Assets	$22.58M	$22.59M	$22.59M
YoY Change	772.78%	774.28%	774.28%
Total Long-Term Assets	$44.69M	$43.64M	$43.64M
YoY Change	134.51%	125.11%	125.11%
TOTAL ASSETS
Total Short-Term Assets	$43.16M	$40.01M	$40.01M
Total Long-Term Assets	$44.69M	$43.64M	$43.64M
Total Assets	$87.85M	$83.65M	$83.65M
YoY Change	88.92%	104.55%	104.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.607M	$2.714M	$2.714M
YoY Change	39.05%	10.93%	10.93%
Accrued Expenses	$6.228M	$5.302M	$5.713M
YoY Change	5.04%	5.03%	12.85%
Deferred Revenue	$13.33K	$13.33K
YoY Change	0.0%	0.0%
Short-Term Debt	$4.000M	$4.000M	$4.000M
YoY Change	0.0%
Long-Term Debt Due	$749.4K	$609.0K	$609.0K
YoY Change	198.24%	95.9%	95.9%
Total Short-Term Liabilities	$14.01M	$13.05M	$13.05M
YoY Change	16.04%	66.59%	66.59%
LONG-TERM LIABILITIES
Long-Term Debt	$4.647M	$4.760M	$4.760M
YoY Change	29.86%	33.65%	33.65%
Other Long-Term Liabilities	$10.93M	$8.261M	$8.261M
YoY Change	1404.73%		1428.11%
Total Long-Term Liabilities	$15.58M	$13.02M	$13.02M
YoY Change	261.92%	217.42%	217.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.01M	$13.05M	$13.05M
Total Long-Term Liabilities	$15.58M	$13.02M	$13.02M
Total Liabilities	$29.60M	$26.07M	$26.07M
YoY Change	80.65%	118.43%	118.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$115.8M	-$116.4M
YoY Change	-14.47%	-14.73%
Common Stock	$1.068M	$1.068M
YoY Change	5.36%	5.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$306.8K	$306.8K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$58.25M	$57.58M	$57.58M
YoY Change
Total Liabilities & Shareholders Equity	$87.85M	$83.65M	$83.65M
YoY Change	88.92%	104.55%	104.55%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$615.8K	$3.326M	$20.11M
YoY Change	-46.07%	-370.56%	464.56%
Depreciation, Depletion And Amortization	$322.1K	$328.4K	$1.321M
YoY Change	-1.88%	-4.57%	3.36%
Cash From Operating Activities	$3.144M	$2.060M	-$3.282M
YoY Change	-216.04%	-30.61%	-198.29%
INVESTING ACTIVITIES
Capital Expenditures	$778.5K	$403.6K	$809.7K
YoY Change		-24.72%	-85.89%
Acquisitions
YoY Change
Other Investing Activities	$15.25K
YoY Change
Cash From Investing Activities	-$1.663M	-$403.6K	-$809.7K
YoY Change		-24.72%	-85.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$174.9K	-361.5K	$3.386M
YoY Change	-104.42%	-97.11%	98.9%
NET CHANGE
Cash From Operating Activities	$3.144M	2.060M	-$3.282M
Cash From Investing Activities	-$1.663M	-403.6K	-$809.7K
Cash From Financing Activities	-$174.9K	-361.5K	$3.386M
Net Change In Cash	$1.306M	1.295M	-$705.6K
YoY Change	4.72%	-112.86%	1.42%
FREE CASH FLOW
Cash From Operating Activities	$3.144M	$2.060M	-$3.282M
Capital Expenditures	$778.5K	$403.6K	$809.7K
Free Cash Flow	$2.366M	$1.656M	-$4.091M
YoY Change	-187.31%	-31.91%	70.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q1	us-gaap	Other Loans Payable OtherLoansPayable		usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	ELTP	Change In Fair Value Of Stockbased Liabilities ChangeInFairValueOfStockbasedLiabilities		usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	ELTP	Deferred Income Tax Asset DeferredIncomeTaxAsset		usd
CY2023	ELTP	Fair Value Of Stockbased Liabilities FairValueOfStockbasedLiabilities		usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2024	ELTP	Noncash Rent Expense And Lease Accretion NoncashRentExpenseAndLeaseAccretion		usd
CY2023	ELTP	Increase Decrease In Finance Lease Liability IncreaseDecreaseInFinanceLeaseLiability		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023	ELTP	Proceeds From Amortization Of Finance Leases Rightofuse Assets ProceedsFromAmortizationOfFinanceLeasesRightofuseAssets		usd
CY2023	ELTP	Recognition Of Right Of Use Asset And Lease Liabilities RecognitionOfRightOfUseAssetAndLeaseLiabilities		usd
CY2024	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther		usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2023Q1	ELTP	Accrued Codevelopment Profit Split AccruedCodevelopmentProfitSplit		usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent		usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q1	ELTP	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	ELTP	Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Financial Instruments EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeFinancialInstruments		usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost		usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits		usd
CY2023Q1	ELTP	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets		usd
CY2023Q1	ELTP	Deferred Tax Assets Capitalization DeferredTaxAssetsCapitalization		usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts		usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q1	ELTP	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset		usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets		usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2024	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	95105235	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1068273108	shares
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	dei	Auditor Name AuditorName	Forvis Mazars, LLP
CY2024	dei	Auditor Location AuditorLocation	Iselin, NJ
CY2024	dei	Auditor Firm AuditorFirmId	686
CY2023	dei	Auditor Name AuditorName	Buchbinder Tunick & Company LLP
CY2023	dei	Auditor Location AuditorLocation	Little Falls, New Jersey 07424
CY2023	dei	Auditor Firm AuditorFirmId	6189
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7106262	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7832247	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	236275	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19453301	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3094549	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	12930464	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	9550716	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	524162	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1032785	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	40014189	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	21510297	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15906853	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14586335	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10175293	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10426158	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6341228	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6341228	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2079658	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2355201	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13062	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	22160895	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2171821	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	432832	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	412434	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	94240	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	21018	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	527072	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	433452	usd
CY2024Q1	us-gaap	Assets Assets	83653536	usd
CY2023Q1	us-gaap	Assets Assets	40896018	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2714306	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2446810	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5301747	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5047726	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13333	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13333	usd
CY2024Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	115822	usd
CY2023Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	110822	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	180399	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	200032	usd
CY2024Q1	us-gaap	Other Loans Payable OtherLoansPayable	4000000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	312739	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	411418	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14914	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13049764	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7833637	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5556	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	18890	usd
CY2024Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	913203	usd
CY2023Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1029018	usd
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	2366487	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	2532502	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1480317	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1957383	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6298008	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	521711	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13020954	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4102121	usd
CY2024Q1	us-gaap	Liabilities Liabilities	26070718	usd
CY2023Q1	us-gaap	Liabilities Liabilities	11935758	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1445000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1445000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1068373108	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1014015081	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1068273108	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1013915081	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1068377	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1014019	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	173210549	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164750980	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	100000	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	100000	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116389267	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136497898	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	57582818	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28960260	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83653536	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40896018	usd
CY2024	ELTP	Revenue From Manufacturing Fees RevenueFromManufacturingFees	54120731	usd
CY2023	ELTP	Revenue From Manufacturing Fees RevenueFromManufacturingFees	29187573	usd
CY2024	ELTP	Revenue From Licensing Fees RevenueFromLicensingFees	2504397	usd
CY2023	ELTP	Revenue From Licensing Fees RevenueFromLicensingFees	4967541	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56625128	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34155114	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	30268025	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	17561093	usd
CY2024	us-gaap	Gross Profit GrossProfit	26357103	usd
CY2023	us-gaap	Gross Profit GrossProfit	16594021	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7145114	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-292807	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1379948	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1263452	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	15568334	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	12918019	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	10788769	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	3676002	usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5776297	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	415126	usd
CY2024	ELTP	Change In Fair Value Of Stockbased Liabilities ChangeInFairValueOfStockbasedLiabilities	-5743468	usd
CY2024	us-gaap	Interest Expense InterestExpense	588622	usd
CY2023	us-gaap	Interest Expense InterestExpense	1112707	usd
CY2024	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1761792	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	20918	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	7453	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10325677	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	309872	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	463092	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3985874	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19645539	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	424028	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	20108631	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3561846	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1015443363	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1012911346	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1023225623	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1012911346	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	25222027	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3561846	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39325	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	77062	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28960260	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28960260	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	20108631	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	159921	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7895020	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	458986	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	57582818	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	57582818	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	20108631	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3561846	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1320518	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1277622	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	236276	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	151066	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	67061	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-292807	usd
CY2024	ELTP	Noncash Compensation Accrued NoncashCompensationAccrued	8354006	usd
CY2023	ELTP	Noncash Compensation Accrued NoncashCompensationAccrued	540000	usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5776297	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	415126	usd
CY2024	ELTP	Deferred Income Tax Asset DeferredIncomeTaxAsset	19989074	usd
CY2024	ELTP	Fair Value Of Stockbased Liabilities FairValueOfStockbasedLiabilities	5743468	usd
CY2024	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1761792	usd
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	159921	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	39325	usd
CY2023	ELTP	Noncash Rent Expense And Lease Accretion NoncashRentExpenseAndLeaseAccretion	803	usd
CY2024	ELTP	Deferred Revenue Expenses DeferredRevenueExpenses	13334	usd
CY2023	ELTP	Deferred Revenue Expenses DeferredRevenueExpenses	13336	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16595028	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36636	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3379748	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2809546	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-435401	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	435116	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7780962	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1336566	usd
CY2024	ELTP	Increase Decrease In Finance Lease Liability IncreaseDecreaseInFinanceLeaseLiability	17126	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-139318	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67566	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3281558	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3338704	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	809653	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5736618	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-809653	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5736618	usd
CY2024	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	125000	usd
CY2023	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	115000	usd
CY2024	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	4000000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12240111	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14438985	usd
CY2024	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	350171	usd
CY2024	ELTP	Proceeds From Amortization Of Finance Leases Rightofuse Assets ProceedsFromAmortizationOfFinanceLeasesRightofuseAssets	46443	usd
CY2024	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	185648	usd
CY2023	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	381675	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3385624	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1702199	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-705587	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-695715	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8244681	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8940396	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7539094	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8244681	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	119412	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1098537	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	292000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	424028	usd
CY2024	ELTP	Stock Issued In Satisfaction Of Accrued Directors Salaries And Consultant Fees StockIssuedInSatisfactionOfAccruedDirectorsSalariesAndConsultantFees	8354006	usd
CY2023	ELTP	Stock Issued In Satisfaction Of Accrued Directors Salaries And Consultant Fees StockIssuedInSatisfactionOfAccruedDirectorsSalariesAndConsultantFees	137062	usd
CY2024	ELTP	Recognition Of Right Of Use Asset And Lease Liabilities RecognitionOfRightOfUseAssetAndLeaseLiabilities	2592233	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7106262	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7832247	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	432832	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	412434	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7539094	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8244681	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zTPQzH14IXgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zVDBhW1qV8Gl">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Such management estimates and assumptions include, but are not limited to, standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred commissions, valuation of intangible assets, the useful life of property and equipment and identifiable intangible assets, stock-based compensation expense and income taxes. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56625128	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34155114	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	432832	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	412434	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	236276	usd
CY2023	ELTP	Finitelived Intangible Assets Impairment FinitelivedIntangibleAssetsImpairment	-292807	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6341228	usd
CY2024	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2024	ELTP	Finitelived Intangible Assets Impairment FinitelivedIntangibleAssetsImpairment	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6341228	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6634035	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2023	ELTP	Finitelived Intangible Assets Impairment FinitelivedIntangibleAssetsImpairment	-292807	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6341228	usd
CY2024	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20108631	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3561846	usd
CY2023	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-415126	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	20108631	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3146720	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1015443363	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1012911346	shares
CY2024	us-gaap	Dilutive Securities DilutiveSecurities	7782260	usd
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1023225623	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1012911346	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	647946	shares
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6298008	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	521711	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	300000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4465970	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2352330	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1804426	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1791311	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	6660068	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5407075	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	12930464	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	9550716	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26082146	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25012493	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15906853	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14586335	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10175293	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10426158	usd
CY2024	us-gaap	Depreciation Depreciation	1320518	usd
CY2023	us-gaap	Depreciation Depreciation	1237770	usd
CY2024Q1	ELTP	Accrued Codevelopment Profit Split AccruedCodevelopmentProfitSplit	3684587	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	485327	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	414989	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	206225	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	125000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	125000	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	90000	usd
CY2024Q1	ELTP	Accrued Director Dues AccruedDirectorDues	22500	usd
CY2023Q1	ELTP	Accrued Director Dues AccruedDirectorDues	70000	usd
CY2024Q1	ELTP	Accrued Consultant Contract Fees AccruedConsultantContractFees	20000	usd
CY2023Q1	ELTP	Accrued Consultant Contract Fees AccruedConsultantContractFees	193333	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4125000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	668108	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	119404	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5301747	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5047726	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	137438	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	1013874	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	18889	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5556	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	32223	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	18890	usd
CY2024	us-gaap	Lessee Finance Lease Description LesseeFinanceLeaseDescription	(i) ownership of the underlying asset transfers to the Company by the end of the lease term; (ii) the lease contains an option to purchase the underlying asset that the Company is reasonably expected to exercise; (iii) the lease term is for a major part of the remaining economic life of the underlying asset; (iv) the present value of the sum of lease payments and any residual value guaranteed by the Company equals or exceeds substantially all of the fair value of the underlying asset; or (v) the underlying asset is of a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term.
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2079658	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2355201	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13062	usd
CY2024Q1	ELTP	Lease Assets LeaseAssets	4434859	usd
CY2023Q1	ELTP	Lease Assets LeaseAssets	13062	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	312739	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	411418	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14914	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1480317	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1957383	usd
CY2024Q1	ELTP	Lease Liabilities LeaseLiabilities	4161857	usd
CY2023Q1	ELTP	Lease Liabilities LeaseLiabilities	14914	usd
CY2024	us-gaap	Payments For Rent PaymentsForRent	0	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	58248	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	629280	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Next Rolling Twelve Months FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths	463734	usd
CY2024Q1	ELTP	Lease Liability Payments Due Next Twelve Months LeaseLiabilityPaymentsDueNextTwelveMonths	1093014	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	623565	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	468391	usd
CY2024Q1	ELTP	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	1091956	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	637050	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	449745	usd
CY2024Q1	ELTP	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	1086795	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	650871	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	449745	usd
CY2024Q1	ELTP	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	1100616	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	440159	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	408453	usd
CY2024Q1	ELTP	Lease Liability Payments Due Year Five LeaseLiabilityPaymentsDueYearFive	848612	usd
CY2024Q1	ELTP	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	6337	usd
CY2024Q1	ELTP	Lease Liability Payments Due After Year Four LeaseLiabilityPaymentsDueAfterYearFour	6337	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	612118	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	453355	usd
CY2024Q1	ELTP	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	1065473	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2368807	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1793050	usd
CY2024Q1	ELTP	Lease Liabilities LeaseLiabilities	4161857	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y7M6D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.095	pure
CY2024Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y1M6D
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y1M6D
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	49534368	shares
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	3125000	usd
CY2024Q1	us-gaap	Share Price SharePrice	0.1543
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7643153	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1068373108	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1068273108	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1014015081	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1013915081	shares
CY2024	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	54358027	shares
CY2023	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2633093	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1014015081	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1011381988	shares
CY2024	ELTP	Common Stock Issued In Payment Of Directors Fees Salaries And Consulting Fees CommonStockIssuedInPaymentOfDirectorsFeesSalariesAndConsultingFees	54358027	shares
CY2023	ELTP	Common Stock Issued In Payment Of Directors Fees Salaries And Consulting Fees CommonStockIssuedInPaymentOfDirectorsFeesSalariesAndConsultingFees	2633093	shares
CY2024	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	54358027	shares
CY2023	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2633093	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1068373108	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1014015081	shares
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.80	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.81	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.79	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.80	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0427	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0469	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0299	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0401	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15370000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.07
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4400000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.09
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	4040000	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.07
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15730000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.05
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1626748	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	343334	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.18
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M18D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	8757	usd
CY2024Q1	ELTP	Price Difference Between Exercise Price And Quoted Price PriceDifferenceBetweenExercisePriceAndQuotedPrice	0.15
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	437921	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y5M4D
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	343000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	424000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	343000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	424000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-19708000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-281000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19989000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19646000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	424000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	99000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	837000	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-10000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	424000	usd
CY2024	ELTP	Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Financial Instruments EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeFinancialInstruments	1213000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	949000	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-11000	usd
CY2024	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-1659000	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	240000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20010000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	837000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19646000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	424000	usd
CY2024Q1	ELTP	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	1034000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	137000	usd
CY2024Q1	ELTP	Deferred Tax Assets Capitalization DeferredTaxAssetsCapitalization	2298000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	59000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15533000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17613000	usd
CY2024Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5232000	usd
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4993000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	24293000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22606000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20434000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24293000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2172000	usd
CY2024Q1	ELTP	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1102000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1030000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2132000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	22161000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2172000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19600000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
CY2024	ELTP	Discrete Tax Benefit DiscreteTaxBenefit	21900000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	74000000.0	usd
CY2024	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	$22.4 million can be carried forward indefinitely with limitation of 80% of taxable income.
CY2024	ELTP	Income Tax Benefit By Judgement IncomeTaxBenefitByJudgement	21900000	usd

Files In Submission

Name	View Source	Status
eltp-20240331_cal.xml	Edgar Link	unprocessable
eltp-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-025829-index-headers.html	Edgar Link	pending
0001493152-24-025829-index.html	Edgar Link	pending
0001493152-24-025829.txt	Edgar Link	pending
0001493152-24-025829-xbrl.zip	Edgar Link	pending
eltp-20240331.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-59.htm	Edgar Link	pending
ex10-59_001.jpg	Edgar Link	pending
ex10-59_002.jpg	Edgar Link	pending
ex10-59_003.jpg	Edgar Link	pending
ex10-59_004.jpg	Edgar Link	pending
ex10-59_005.jpg	Edgar Link	pending
ex10-59_006.jpg	Edgar Link	pending
ex10-59_007.jpg	Edgar Link	pending
ex10-59_008.jpg	Edgar Link	pending
ex10-59_009.jpg	Edgar Link	pending
ex10-59_010.jpg	Edgar Link	pending
ex10-59_011.jpg	Edgar Link	pending
ex10-59_012.jpg	Edgar Link	pending
ex10-59_013.jpg	Edgar Link	pending
ex10-59_014.jpg	Edgar Link	pending
ex10-59_015.jpg	Edgar Link	pending
ex10-59_016.jpg	Edgar Link	pending
ex10-59_017.jpg	Edgar Link	pending
ex10-59_018.jpg	Edgar Link	pending
ex10-59_019.jpg	Edgar Link	pending
ex10-59_020.jpg	Edgar Link	pending
ex10-59_021.jpg	Edgar Link	pending
ex10-59_022.jpg	Edgar Link	pending
ex10-59_023.jpg	Edgar Link	pending
ex10-59_024.jpg	Edgar Link	pending
ex10-59_025.jpg	Edgar Link	pending
ex10-59_026.jpg	Edgar Link	pending
ex10-59_027.jpg	Edgar Link	pending
ex10-59_028.jpg	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
eltp-20240331_def.xml	Edgar Link	unprocessable
eltp-20240331_lab.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2024 Q2 Form 10-K Financial Statement

#000149315224025829 Filed on July 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2024 Q2 Form 10-K Financial Statement

#000149315224025829 Filed on July 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp